These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10456955)

  • 21. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
    Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
    Chakir H; Campos-Neto A; Mojibian M; Webb JR
    Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.
    Ronet C; Hauyon-La Torre Y; Revaz-Breton M; Mastelic B; Tacchini-Cottier F; Louis J; Launois P
    J Immunol; 2010 Jan; 184(2):886-94. PubMed ID: 19966209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polarized helper-T-cell responses against Leishmania major in the absence of B cells.
    Brown DR; Reiner SL
    Infect Immun; 1999 Jan; 67(1):266-70. PubMed ID: 9864225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An opposite role is exerted by the acarian Myocoptes musculinus in the outcome of Toxoplasma gondii infection according to the route of the protozoa inoculation.
    Welter A; Mineo JR; Silva DA; Lourenço EV; Ferro EA; Roque-Barreira MC; da Silva NM
    Microbes Infect; 2006 Sep; 8(11):2618-28. PubMed ID: 17055964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional and quantitative analysis of splenic T cell immune responses following oral toxoplasma gondii infection in mice.
    Lee YH; Channon JY; Matsuura T; Schwartzman JD; Shin DW; Kasper LH
    Exp Parasitol; 1999 Mar; 91(3):212-21. PubMed ID: 10072323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell and non-T cell compartments can independently determine resistance to Leishmania major.
    Shankar AH; Titus RG
    J Exp Med; 1995 Mar; 181(3):845-55. PubMed ID: 7869047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice.
    Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Dainichi T; Asao T; Katunuma N; Himeno K
    Int Immunol; 2001 Aug; 13(8):975-82. PubMed ID: 11470767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Launois P; Himmelrich H; Tacchini-Cottier F; Milon G; Louis JA
    Microbes Infect; 1999 Jan; 1(1):59-64. PubMed ID: 10847767
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice.
    Hondowicz BD; Park AY; Elloso MM; Scott P
    Eur J Immunol; 2000 Jul; 30(7):2007-14. PubMed ID: 10940890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Leishmania major LACK antigen with an immunodominant epitope at amino acids 156 to 173 is not required for early Th2 development in BALB/c mice.
    Kelly BL; Locksley RM
    Infect Immun; 2004 Dec; 72(12):6924-31. PubMed ID: 15557613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coinfection with Listeria monocytogenes potentlxtes the response of BALB/c mice against Leishmania major.
    Tabbara KS; Al-Azmi AS; Al Salem JA
    J Egypt Soc Parasitol; 2004 Apr; 34(1):349-66. PubMed ID: 15125539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection.
    Guéry JC; Galbiati F; Smiroldo S; Adorini L
    J Immunol; 1997 Sep; 159(5):2147-53. PubMed ID: 9278301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JNK1 is required for T cell-mediated immunity against Leishmania major infection.
    Constant SL; Dong C; Yang DD; Wysk M; Davis RJ; Flavell RA
    J Immunol; 2000 Sep; 165(5):2671-6. PubMed ID: 10946297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.